Chemical eye corrosivity testing determines whether a substance or mixture can cause irreversible damage to ocular tissue, providing the scientific basis for GHS hazard classification, product labeling, and safety data sheet preparation under regulatory frameworks such as REACH and CLP. Modern testing strategies increasingly rely on validated in vitro methods, including the BCOP, ICE, STE, and RhCE assays described in OECD test guidelines, which substantially reduce animal use while delivering regulatory-accepted results. This article outlines the technical principles, applicable standards, sample types, testing items, analytical methods, and frequently asked questions related to chemical eye corrosivity evaluation.
Technical Overview
Eye corrosion, formally designated as "serious eye damage" under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), refers to the production of tissue damage in the eye, or a serious physical decay of vision, following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of exposure. Eye irritation, by contrast, describes fully reversible inflammatory changes within the same observation period. Distinguishing between these two outcomes determines whether a product is classified as GHS Category 1 (serious eye damage) or Category 2A/2B (eye irritation), which directly affects labeling elements such as the hazard pictogram, the signal word, and hazard statements H318 ("Causes serious eye damage") and H319 ("Causes serious eye irritation").
Historically, this endpoint was assessed using the in vivo rabbit eye test (the Draize test). Regulatory frameworks worldwide, however, now mandate a hierarchical, animal-sparing strategy: existing human and animal data, physicochemical properties such as pH and buffering capacity, structure-activity relationships, and read-across from analogues are evaluated first, followed by validated in vitro methods, with in vivo testing permitted only as a last resort. The principal standards and guidelines governing this field include:
- OECD Test Guideline 405 – Acute Eye Irritation/Corrosion (in vivo rabbit eye test, last-resort use)
- OECD Test Guideline 437 – Bovine Corneal Opacity and Permeability (BCOP) test method
- OECD Test Guideline 438 – Isolated Chicken Eye (ICE) test method
- OECD Test Guideline 491 – Short Time Exposure (STE) test method
- OECD Test Guideline 492 – Reconstructed human Cornea-like Epithelium (RhCE) test method
- GB/T 21609-2008 – Chinese national standard for the acute eye irritation/corrosion test of chemicals
- GB 30000 series – Chinese national standards implementing GHS classification and labelling
- ISO 10993-23 – Biological evaluation of medical devices, irritation testing including ocular endpoints
- UN GHS and EU CLP Regulation (EC) No 1272/2008, Annex I, Part 3.3 – classification criteria for serious eye damage and eye irritation
Testing is organized within integrated approaches known as defined strategies. A top-down strategy is applied when a substance is suspected of being severely damaging (for example, formulations containing high levels of surfactants or extreme pH), beginning with methods capable of identifying Category 1 effects. A bottom-up strategy is applied when a substance is expected to be mild or non-irritating, beginning with methods that screen out non-classified chemicals. Accredited third-party laboratories select the appropriate sequence based on the chemical space, physical form, and regulatory purpose of the submission.
Testing Samples
Eye corrosivity testing is performed on an exceptionally broad range of sample types, spanning pure substances, technical mixtures, and finished commercial formulations across virtually every chemical-consuming industry.
Industrial Chemicals and Intermediates
Monomers, solvents, acids, alkalis, oxidizing and reducing agents, salts, and synthetic intermediates submitted for new chemical notification, REACH registration, or national inventory listing. Both single substances and multi-component reaction mixtures are tested, with sample identity, purity, and impurity profile documented to support regulatory interpretation of results.
Surfactants, Detergents, and Cleaning Formulations
Anionic, nonionic, cationic, and amphoteric surfactants, along with concentrated laundry powders, liquid detergents, degreasers, institutional cleaners, and vehicle-care products. Surfactant-rich matrices are a priority sector because of their welldocumented potential for ocular irritation and, at high concentrations, serious eye damage.
Cosmetics and Personal Care Products
Raw ingredients, preservatives, and finished rinse-off and leave-on products such as shampoos, cleansers, mascaras, and eye creams. Because cosmetics marketed in the EU and several other jurisdictions are subject to animal testing bans, in vitro methods such as the RhCE test are the primary route for ocular safety assessment and are documented within the product safety report required under Regulation (EC) No 1223/2009.
Pesticides, Biocides, and Disinfectants
Active substances, technical concentrates, and diluted end-use formulations, including surface disinfectants and alcohol-based biocidal products. Regulatory schemes for plant protection products and biocides typically require ocular hazard data to support classification, labeling, and directions for safe use.
Consumer, Household, and Workplace Products
Air fresheners, polishes, adhesives, paints, automotive fluids, aerosols, and other retail or professional products that may accidentally contact the eye during foreseeable use or misuse. Results inform precautionary labeling and first-aid instructions on consumer packaging.
Medical Devices
Polymeric materials, elastomers, coatings, and device extracts evaluated within biological risk management programs. Ocular irritation potential of devices intended for eye contact or devices with routeway exposure is assessed under the ISO 10993 series, with irritation endpoints now addressed by ISO 10993-23.
Testing Items
Core testing items are structured to deliver a classification decision under the applicable GHS-based regime, supported by quantitative mechanistic endpoints from each in vitro system. Typical items include:
- Identification of serious eye damage potential corresponding to GHS Category 1 (irreversible ocular effects)
- Classification of eye irritation potential corresponding to GHS Category 2A (irritating) or Category 2B (mildly irritating)
- BCOP endpoints: corneal opacity measurement, sodium fluorescein permeability determination, and calculation of the In Vitro Irritancy Score (IVIS)
- ICE endpoints: corneal swelling, corneal opacity, fluorescein retention, and morphological observations, integrated into an overall irritancy class
- Cell viability endpoints for the STE and RhCE methods, quantified by MTT reduction
- Supporting physicochemical parameters: pH measurement and acid/alkali reserve (buffering capacity) as corrosion predictors
- Reversibility assessment through in vivo follow-up, where scientifically and ethically justified
- (Q)SAR predictions and read-across documentation supporting weight-of-evidence conclusions
Testing Methods
Initial Considerations and Pre-Screening
Before any laboratory work, a weight-of-evidence review is conducted covering existing human data (for example, occupational accident records), prior animal studies, (Q)SAR model outputs, and analog data. Substances exhibiting pH of 2.0 or lower, or 11.5 or higher, together with significant buffering capacity, may be presumed to cause serious eye damage and classified as Category 1 without additional testing, provided that acid/alkali reserve analysis supports the conclusion. Strong evidence of skin corrosion also supports a presumption of serious eye damage.
Bovine Corneal Opacity and Permeability Test (OECD TG 437)
The BCOP test uses isolated bovine corneas mounted in specially designed holders. Test substances are applied to the epithelial surface for a defined exposure period, after which corneal opacity is measured quantitatively with an opacitometer and permeability is assessed by the penetration of sodium fluorescein dye. The combined In Vitro Irritancy Score is calculated as opacity plus fifteen times the permeability value. An IVIS of 55.1 or greater identifies the test substance as GHS Category 1, while an IVIS of 3.0 or lower supports no classification; intermediate values are inconclusive and require complementary testing. The method is suited to both liquids and solids across a broad chemical domain.
Isolated Chicken Eye Test (OECD TG 438)
The ICE test uses enucleated chicken eyes from slaughterhouse material, maintained in a superfusion apparatus that preserves corneal physiology. After exposure, three endpoints are scored at defined intervals: corneal swelling measured by optical pachymetry or thickness gauge, corneal opacity assessed by slit-lamp observation, and fluorescein retention indicating epithelial integrity. The endpoint combination assigns an overall irritancy class from Class 1 (severe, consistent with Category 1) to Class 4 (minimal or no effect, consistent with no classification), while intermediate classes are considered inconclusive. The method performs particularly well for alcohols, ketones, and certain surfactant-containing formulations.
Short Time Exposure Test (OECD TG 491)
The STE test employs cultures of rabbit corneal epithelial cells exposed to the test chemical for five minutes, simulating the earliest phase of accidental ocular contact. Cell viability is subsequently quantified by MTT assay. Viability at or below the 70% decision threshold indicates the presence of an ocular hazard requiring classification, consistent with identification of chemicals inducing serious eye damage within the defined applicability domain, whereas viability above the threshold supports a conclusion of no classification when the method is used in a bottom-up strategy. The short exposure design makes the assay rapid and particularly useful for screening large numbers of test articles.
Reconstructed Human Cornea-like Epithelium Test (OECD TG 492)
The RhCE test uses three-dimensional tissue models constructed from immortalized or primary human corneal epithelial cells cultured on permeable supports, reproducing a stratified, cornea-like epithelial barrier. Test substances are applied topically (typically 30 minutes for liquids and six hours for solids), and tissue viability is measured by MTT reduction. Viability at or below 60% indicates that the substance is either Category 1 or Category 2, although the method alone cannot distinguish between them; viability above 60% supports no classification within the bottom-up approach, with documented limitations for certain chemical classes. Because the model is of human origin and is compatible with both finished products and ingredients, it is the workhorse method for cosmetic and consumer-product ocular safety assessment.
In Vivo Rabbit Eye Test (OECD TG 405)
The traditional in vivo test in albino rabbits remains available only as a last resort, after all alternative sources of information have been exhausted and an in vivo result is scientifically and legally required. The procedure uses a sequential dosing scheme beginning with a single animal, application of the substance into the conjunctival sac, and grading of corneal opacity, iritis, conjunctival redness, and chemosis at 24, 48, and 72 hours, with observation for up to 21 days to establish reversibility. Humane endpoints and anesthetic provisions are mandatory. The Chinese national standard GB/T 21609-2008 describes an equivalent in vivo procedure for domestic chemical notifications.
Integrated Testing Strategy
In practice, laboratories combine methods in a decision-tree logic. A typical top-down workflow for a suspected severe irritant applies BCOP or ICE first to confirm or rule out Category 1; a negative outcome triggers RhCE or STE testing to complete classification. A typical bottom-up workflow for an expected mild product applies the RhCE test first; only if viability falls below the threshold is confirmatory BCOP or ICE testing initiated. The final classification integrates all lines of evidence and is reported with the applicable GHS category, hazard statements, and labeling recommendations.
Applications
Eye corrosivity test data are embedded in nearly every regulatory and commercial decision point in the chemical product lifecycle. Key applications include:
- GHS, CLP, and GB 30000 classification and labelling, including pictogram selection, signal word assignment, and H318/H319 hazard statements for labels and packaging
- REACH registration dossiers and new chemical notifications, where ocular hazard data are required endpoints at relevant tonnage bands
- Safety data sheet preparation, particularly Sections 2 (hazard identification) and 11 (toxicological information)
- Cosmetic product safety reports and safety substantiation files under Regulation (EC) No 1223/2009 and equivalent national regimes
- Transport of dangerous goods evaluations and occupational hazard communication programs, including selection of eye protection and emergency eyewash provisions
- Research, development, and reformulation support, including comparative benchmarking of ingredient candidates and verification of reduced-irritation marketing claims
- Medical device biological evaluation files under the ISO 10993 series supporting regulatory submission and risk management
By anchoring these decisions to validated, standards-based test data, manufacturers and accredited third-party laboratories can demonstrate regulatory compliance, protect end users, and defend product claims across global markets.
FAQ
What is the difference between eye corrosion and eye irritation?
Eye corrosion (serious eye damage) involves irreversible tissue injury, such as persistent corneal opacity or tissue necrosis, that does not fully resolve within 21 days, and corresponds to GHS Category 1 with the hazard statement H318. Eye irritation involves reversible inflammatory responses, including transient opacity, redness, and swelling, that fully resolve within the observation period, and corresponds to GHS Category 2A or 2B with the hazard statement H319.
Are animal tests still required for eye corrosivity assessment?
In most jurisdictions, animal testing is a last resort. Regulatory agencies expect a weight-of-evidence approach built on existing data, physicochemical indicators, (Q)SAR, and validated in vitro methods (OECD TG 437, 438, 491, and 492). In vivo testing under OECD TG 405 is only acceptable when alternative approaches cannot resolve the classification question and a legal requirement for in vivo data exists. For cosmetics in the EU and several other markets, animal testing is prohibited outright, making in vitro strategies the only compliant route.
When can a chemical be classified as corrosive to the eye without testing?
A substance with pH of 2.0 or lower or 11.5 or higher, together with high buffering capacity, may be classified as GHS Category 1 based on physicochemical data alone. Compelling evidence of severe skin corrosion also supports presumptive classification. In these cases, corrosivity is considered an intrinsic property, and confirmatory animal testing is discouraged on both scientific and ethical grounds.
Can in vitro methods distinguish Category 1 from Category 2?
Yes, partially. BCOP (OECD TG 437) and ICE (OECD TG 438) can identify Category 1 substances when their decision thresholds are exceeded, and they can screen out non-classified substances. The RhCE (OECD TG 492) and STE (OECD TG 491) methods reliably identify non-classified substances but produce a combined positive signal that cannot, on their own, separate Category 1 from Category 2. This is why regulatory testing strategies chain multiple methods, using the strengths of each to arrive at a definitive category.
How are mixtures evaluated?
Mixtures can be assessed by testing the formulation itself using the in vitro methods described above, by applying additivity rules from classified components, or by bridging principles when sufficient data on similar mixtures exist. Testing the whole formulation with BCOP or RhCE assays is common for detergents, cosmetics, and disinfectants because it captures synergistic and antagonistic interactions between ingredients that calculation methods cannot predict.
How much sample is required, and what is the typical turnaround time?
Sample requirements depend on the method: RhCE and STE assays generally require only a few grams or milliliters, while BCOP and ICE tests, which run multiple corneas per dose group, may require larger quantities, typically in the range of tens of grams for solids or milliliters for liquids. Turnaround times range from approximately one to two weeks for a single in vitro assay to several weeks for a tiered strategy involving multiple methods, with in vivo studies, where exceptionally justified, extending to a month or longer due to the 21-day observation period. Accredited third-party laboratories provide detailed protocols, sample handling instructions, and study timelines before initiation.